27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
Presented below is our summary of significant Internal Revenue Service (IRS) guidance and relevant t...
Read More >
New Anti-Power Harassment Law (Anti-Bullying Law) in Japan - New Legislation Enacted - On May 29, ...
Read More >
We recently published a client alert concerning pending New York State legislation expanding worker ...
Read More >
Glynn v. Superior Court, 42 Cal. App. 5th 47 (2019) - John Glynn worked as a pharmaceutical sales ...
Read More >
The National Labor Relations Board (the Board) continued its recent trend of year-end activity by is...
Read More >
During the final months of 2019, the Mine Safety and Health Administration (“MSHA”) advised the mi...
Read More >